ACONW - Aclarion Inc

0.0351
-0.004   -9.972%

Share volume: 1,700
Last Updated: 04-09-2025
Healthcare/Services – Health: 0.92%

PREVIOUS CLOSE
CHG
CHG%
$0.04
0.00
-0.09%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
34%
Profitability 25%
Dept financing 17%
Liquidity 19%
Performance 50%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-24.84%
1 Month
-39.17%
3 Months
-2.23%
6 Months
5.09%
1 Year
25.81%
2 Year
40.40%
Key data
Stock price
$0.04
P/E Ratio 
0.00
DAY RANGE
$0.04 - $0.04
EPS 
-$0.92
52 WEEK RANGE
$0.01 - $0.24
52 WEEK CHANGE
$35.52
MARKET CAP 
1.579 M
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.49
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$8,374
AVERAGE 30 VOLUME 
$9,288
Company detail
CEO: Brent Ness
Region: US
Website: aclarion.com
Employees: 7
IPO year: 2022
Issue type:
Market: NASDAQ
Industry: Healthcare/Services – Health
Sector: Services

Aclarion, Inc. develops software application for magnetic resonance spectroscopy (MRS) in the U.S. It offers NOCISCAN-LS Post-Processor suite, NOCICALC-LS, and NOCIGRAM-LS. The company was formerly known as Nocimed, which changed its name to ACLarion in December 2021.

Recent news
loading